Skip to content

Comparison of the effectiveness between two treatment method in anxiety

Comparison of The effectiveness between cognitive-behavior group therapy and mindfulness based cognitive therapy in improvement of females with generalized anxiety disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012121711789N1
Enrollment
36
Registered
2016-06-27
Start date
2012-10-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder. Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is

Interventions

Intervention 1: Intervention group 1: Cognitive behavior group therapy that contains 10 sessions. Each session takes 90 minutes and hold once a week. Intervention 2: Intervention group 2: Mindfulness
Behavior
Intervention group 1: Cognitive behavior group therapy that contains 10 sessions. Each session takes 90 minutes and hold once a week.
Intervention group 2: Mindfulness based cognitive group therapy contains 10 sessions. Each session takes 90 minutes and hold once a week. There was no control group.
Control group: There was no control group

Sponsors

Investigator
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: having diagnosed of GAD based on semi structured interview. Regarding the high co morbidity of GAD with other disorder, patient selected that have the primary diagnose of GAD; minimum level of the third grade of primary school. Exclusion criteria: having severe personality disorder; having the diagnose of psychotic or bipolar disorder; currently use of psychotherapy or medication; having the history of psychotherapy before the research; having disabling somatic decease; alcohol or substance addiction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
GAD sign and symptom. Timepoint: pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: GAD-7 questionnare.;Worry. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: PSWQ.;Cognitive avoidance. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: CAQ.;Emotion regulation. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: DERS.;Quality of life. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: WHO- QOL- BREF.;Mindfulness attention. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: MAAS.;Self compassion. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: SCS.;Beliefs about worry. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: wwq-II.;Problem solving. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: PSI.;Relationship with child. Timepoint: Pre treatment, after the termination of treatment, 4 months after the treatment. Method of measurement: CPRS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Fereshte Momeni

Shahid Beheshti University

f_momeni@sbu.ac.ir+98 21 8801 9479

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026